Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences NGS, SCA, Mass Spec: The Road to Diagnostics

Yong Zeng's Biography



Yong Zeng, Associate Professor, University of Florida

Dr. Zeng is an associate professor of chemistry and affiliate faculty of Biomedical Engineering at the University of Florida, and a member of UF Health Cancer Center. He obtained his PhD in Chemistry from University of Alberta, Canada and completed the postdoc training at University of California, Berkeley. Dr. Zeng’s research draws on chemistry, nanomaterials, bioengineering, and medicine to develop innovative micro and nanoscale tools to advance precision medicine of cancer. His technology innovations span from biomolecular assays to micro/nano systems for sensitive measurements of liquid biopsies and molecular biomarkers. His group is also devoted to translational research to bring the technological innovations to clinical sciences, closely collaborating with biologists and clinicians. Dr. Zeng is internationally recognized for his pioneering research in developing microfluidic technologies for isolation and analysis of tumor-derived extracellular vesicles (EVs) for cancer diagnostics and therapeutics. His research programs have been continuously funded by NIH and other funding agencies and led to many highly visible publications on top-tier journals, including Nat. Biomed. Eng. and Sci. Transl. Med., which were featured in public media outlets such as the NIH Director’s Blog and the JAMA Network.

Yong Zeng Image

Microfluidic Bioaffinity Assays: Improving Detection and Molecular Profiling of Disease Biomarkers

Monday, 28 September 2015 at 13:30

Add to Calendar ▼2015-09-28 13:30:002015-09-28 14:30:00Europe/LondonMicrofluidic Bioaffinity Assays: Improving Detection and Molecular Profiling of Disease BiomarkersNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com

Molecular recognition or bioaffinity interaction is an essential principle underlying a vast array of biotechnologies and applications, such as biosensing and drug delivery.  Here we will discuss our studies on exploring microfluidic principles to advance bioaffinity-based assays for quantitative detection and biochemical characterization of circulating cancer biomarkers.  More specifically, this presentation will be focused on microfluidic engineering of both immunoassays and lectin array to substantially improve the assay performance.  Their applications to detection and glycan profiling of circulating proteins markers and exosomes associated with tumors will be presented to demonstrate the potential use for cancer diagnosis.


Add to Calendar ▼2015-09-28 00:00:002015-09-30 00:00:00Europe/LondonNGS, SCA, Mass Spec: The Road to DiagnosticsNGS, SCA, Mass Spec: The Road to Diagnostics in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com